Back

VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

iwNHL 2015 | Therapeutic opportunities for lenalidomide in non-Hodgkin lymphoma

At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Nathan H. Fowler, MD, of The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the ongoing clinical trials that are investigating the use of lenalidomide, an immunomodulatory drug, as monotherapy or in combination for the treatment of different subtypes of non-Hodgkin lymphoma.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter